Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Marie, Selvy"'
Autor:
Marie Selvy, Catherine Mattévi, Cristelle Dalbos, Youssef Aissouni, Eric Chapuy, Pierre-Yves Martin, Aurore Collin, Damien Richard, Charles Dumontet, Jérôme Busserolles, Sakahlé Condé, David Balayssac
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112915- (2022)
Background: Donepezil, a cholinesterase inhibitor approved in Alzheimer’s disease, has demonstrated analgesic and preventive effects in animal models of oxaliplatin-induced neuropathy. To improve the clinical interest of donepezil for the managemen
Externí odkaz:
https://doaj.org/article/4a3c89020b1444e2ae268de916d99bee
Autor:
Nicolas Kerckhove, Marie Selvy, Céline Lambert, Coralie Gonneau, Gabrielle Feydel, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouché, Florian Slimano, Vincent Bourgeois, Valérie Lebrun-Ly, Frédéric Thuillier, Thibault Mazard, David Tavan, Kheir Eddine Benmammar, Brigitte Monange, Mohamed Ramdani, Denis Péré-Vergé, Floriane Huet-Penz, Ahmed Bedjaoui, Florent Genty, Cécile Leyronnas, Jérôme Busserolles, Sophie Trévis, Vincent Pinon, Denis Pezet, David Balayssac
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in color
Externí odkaz:
https://doaj.org/article/2b597ee8a3434985a82d29f25ae2a813
Autor:
Marie Selvy, Nicolas Kerckhove, Bruno Pereira, Fantine Barreau, Daniel Nguyen, Jérôme Busserolles, Fabrice Giraudet, Aurélie Cabrespine, Carine Chaleteix, Martin Soubrier, Jacques-Olivier Bay, Richard Lemal, David Balayssac
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is associated with psychological distress and a decrease
Externí odkaz:
https://doaj.org/article/c75b1e63fec145cca6c61e7e53c3319c
Publikováno v:
Langenbeck's Archives of Surgery. 407:15-23
AIM OF THE STUDY To review and to analyse the feasibility of using no urinary catheter or a catheter for less than 24 h compared with longer post-operative catheter after colorectal surgery with infraperitoneal dissection. METHODS We performed a syst
Publikováno v:
Journal de Chirurgie Viscérale. 158:S13-S18
Resume Le but de cet article est de presenter le concept de la medecine 4P qui est une medecine personnalisee, preventive, predictive, et participative. Sont discutes l’evolution du concept de la medecine traditionnelle a dominante curative vers la
Publikováno v:
Journal of Visceral Surgery. 158:S12-S17
The aim of this article is to present the concept of "4P medicine" i.e., medicine that is Personalized, Preventive, Predictive, and Participatory. We will discuss the evolution from cure-focused traditional medicine toward personalized medicine based
Autor:
Marie Selvy, David Balayssac, Anthony Martelin, Xavier Armoiry, Caroline Giroudon, Delphine Cabelguenne
Publikováno v:
World Journal of Surgery
World Journal of Surgery, 2021, 45, pp.705-718. ⟨10.1007/s00268-020-05869-5⟩
World journal of surgery
World journal of surgery, 2021, 45, pp.705-718. ⟨10.1007/s00268-020-05869-5⟩
World Journal of Surgery, 2021, 45, pp.705-718. ⟨10.1007/s00268-020-05869-5⟩
World journal of surgery
World journal of surgery, 2021, 45, pp.705-718. ⟨10.1007/s00268-020-05869-5⟩
Several low-impact laparoscopic strategies have been developed to improve the safety of pneumoperitoneum. We conducted a systematic review to establish the current evidence base for the use of the AIRSEAL® insufflation device for low-pressure pneumo
Autor:
Cindy Vuillermet, Hélène Meillat, Gilles Manceau, Ben Creavin, Clarisse Eveno, Stéphane Benoist, Yann Parc, Jérémie H. Lefevre, Sara Arfa, Paul-Noël Dumont, Hortense Boullenois, David Fuks, Mehdi Ouaissi, Leonor Benhaim, Marie Selvy, Jean-Jacques Tuech, Zaher Lakkis, Renato Lupinacci, Antoine Epin, Sophie Deguelte, Guillaume Passot, Bertrand Trilling, Cécile Jarlot-Gas, Muriel Mathonnet, David Moszkowicz, Leila M’Harzi, Laura Beyer Berjot
Publikováno v:
Surgery
Surgery, Elsevier, 2020, 168 (5), pp.786-792. ⟨10.1016/j.surg.2020.06.021⟩
Surgery, Elsevier, 2020, 168 (5), pp.786-792. ⟨10.1016/j.surg.2020.06.021⟩
International audience; BackgroundBladder invasion by colon cancer is rare; however, its management is still controversial. Our objective was to report outcomes and identify risk factors for local recurrence in colon cancer with clinically suspected
Autor:
Fabrice Giraudet, Marie Selvy, Nicolas Kerckhove, Bruno Pereira, Fantine Barreau, Daniel Nguyen, Jérôme Busserolles, Aurélie Cabrespine, Carine Chaleteix, Martin Soubrier, Jacques-Olivier Bay, Richard Lemal, David Balayssac
Publikováno v:
European Archives of Oto-Rhino-Laryngology
European Archives of Oto-Rhino-Laryngology, Springer Verlag, 2022, 279 (4), pp.2197-2201. ⟨10.1007/s00405-021-07234-1⟩
European Archives of Oto-Rhino-Laryngology, Springer Verlag, 2022, 279 (4), pp.2197-2201. ⟨10.1007/s00405-021-07234-1⟩
International audience; Purpose Bortezomib is a neurotoxic drug used in multiple myeloma and responsible for chemotherapy-induced peripheral neuropathy (CIPN). In a previous cross-sectional study, CIPN prevalence was about 26.9% in 67 patients. A sec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8b597dbb2d5da26df12ddfc50c6a52
https://hal.inrae.fr/hal-03813006
https://hal.inrae.fr/hal-03813006
Autor:
Nicolas Kerckhove, Mélissa Cuménal, Christine Courteix, David Balayssac, Jérôme Busserolles, Marie Selvy
Publikováno v:
Expert Opinion on Drug Safety
Expert Opinion on Drug Safety, Informa Healthcare, 2020, 19 (6), pp.707-733. ⟨10.1080/14740338.2020.1764934⟩
Expert Opinion on Drug Safety, Informa Healthcare, 2020, 19 (6), pp.707-733. ⟨10.1080/14740338.2020.1764934⟩
Peripheral neuropathic pain is a highly disabling condition for patients and a challenge for neurologists and pain physicians. Although many drugs have been assessed in scientific studies, few have demonstrated a clear clinical efficacy against neuro